PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $121,511 | -46.2% | 5,042 | -76.4% | 0.00% | – |
| Q4 2022 | $226,000 | -53.0% | 21,349 | -80.0% | 0.00% | -100.0% |
| Q3 2022 | $481,000 | +30.4% | 106,936 | +16.1% | 0.00% | 0.0% |
| Q2 2022 | $369,000 | -34.1% | 92,086 | +20.4% | 0.00% | 0.0% |
| Q1 2022 | $560,000 | +52.2% | 76,496 | +16.9% | 0.00% | 0.0% |
| Q4 2021 | $368,000 | -16.6% | 65,453 | -5.0% | 0.00% | 0.0% |
| Q3 2021 | $441,000 | -21.8% | 68,926 | +3.0% | 0.00% | 0.0% |
| Q2 2021 | $564,000 | +4.4% | 66,917 | +30.2% | 0.00% | 0.0% |
| Q1 2021 | $540,000 | -39.3% | 51,382 | -2.3% | 0.00% | -50.0% |
| Q4 2020 | $890,000 | +33.0% | 52,597 | +0.9% | 0.00% | 0.0% |
| Q3 2020 | $669,000 | +181.1% | 52,140 | +208.2% | 0.00% | +100.0% |
| Q2 2020 | $238,000 | +114.4% | 16,917 | +40.4% | 0.00% | – |
| Q1 2020 | $111,000 | – | 12,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|